HomeHealthcare & Life Sciences Benign Prostatic Hyperplasia Treatment Market

Global Benign Prostatic Hyperplasia Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological treatmentAlpha-blockersTamsulosinSilodosinAlfuzosinDoxazosinOther alpha-blockers5-alpha reductase inhibitors (5-ARI)DutasterideFinasterideCombination therapyAlpha-blockers + 5-arisAlpha-blockers + pde5 inhibitorsPhosphodiesterase-5 inhibitors (pde5 inhibitors)Herbal and other drugs, Surgical treatmentTransurethral resection of the prostate (TURP)Transurethral incision of t

Starting From
USD 3950

Buy Now

Report Benefits

Develop business strategies by understanding the trends shaping and driving the Market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track sales in the global and country-specific Market.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Market Segmentation

Benign Prostatic Hyperplasia Treatment Market, By Treatment Type (Million 2022-2034)
- Pharmacological treatment
  - Alpha-blockers
    - Tamsulosin
    - Silodosin
    - Alfuzosin
    - Doxazosin
    - Other alpha-blockers
  - 5-alpha reductase inhibitors (5-ARI)
    - Dutasteride
    - Finasteride
  - Combination therapy
    - Alpha-blockers + 5-aris
    - Alpha-blockers + pde5 inhibitors
  - Phosphodiesterase-5 inhibitors (pde5 inhibitors)
  - Herbal and other drugs
- Surgical treatment
  - Transurethral resection of the prostate (TURP)
  - Transurethral incision of the prostate (TUIP)
  - Open prostatectomy
  - Laser therapy
    - Holmium laser enucleation of the prostate (HOLEP)
    - Photoselective vaporisation of the prostate (PVP)
- Minimally invasive procedures
  - Urolift system
  - RezÅ«m water vapour therapy
  - Prostatic artery embolisation
  - Microwave thermotherapy
  - Transurethral needle ablation (TUNA)
- Other treatments
  - Lifestyle modifications
  - Watchful waiting / active surveillance
Benign Prostatic Hyperplasia Treatment Market, By End Use (Million 2022-2034)
- Hospitals
- Clinics
- Ambulatory surgical centres
- Specialty urology centers
Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group (Million 2022-2034)
- Below 50 years
- 50–60 years
- Above 60 years
Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel (Million 2022-2034)
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
Regional Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel (Million 2022-2034)
- North America
  - North America Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
    - Pharmacological treatment
    - Surgical treatment
    - Minimally invasive procedures
    - Other treatments
  - North America Benign Prostatic Hyperplasia Treatment Market, By End Use
    - Hospitals
    - Clinics
    - Ambulatory surgical centres
    - Specialty urology centers
  - North America Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
    - Below 50 years
    - 50–60 years
    - Above 60 years
  - North America Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
    - Hospital pharmacy
    - Retail pharmacy
    - Online pharmacy
  - U.S.
    - U.S. Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
      - Pharmacological treatment
      - Surgical treatment
      - Minimally invasive procedures
      - Other treatments
    - U.S. Benign Prostatic Hyperplasia Treatment Market, By End Use
      - Hospitals
      - Clinics
      - Ambulatory surgical centres
      - Specialty urology centers
    - U.S. Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
      - Below 50 years
      - 50–60 years
      - Above 60 years
    - U.S. Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
      - Hospital pharmacy
      - Retail pharmacy
      - Online pharmacy
  - Canada
- Europe
  - Europe Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
    - Pharmacological treatment
    - Surgical treatment
    - Minimally invasive procedures
    - Other treatments
  - Europe Benign Prostatic Hyperplasia Treatment Market, By End Use
    - Hospitals
    - Clinics
    - Ambulatory surgical centres
    - Specialty urology centers
  - Europe Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
    - Below 50 years
    - 50–60 years
    - Above 60 years
  - Europe Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
    - Hospital pharmacy
    - Retail pharmacy
    - Online pharmacy
  - U.K.
    - U.K. Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
      - Pharmacological treatment
      - Surgical treatment
      - Minimally invasive procedures
      - Other treatments
    - U.K. Benign Prostatic Hyperplasia Treatment Market, By End Use
      - Hospitals
      - Clinics
      - Ambulatory surgical centres
      - Specialty urology centers
    - U.K. Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
      - Below 50 years
      - 50–60 years
      - Above 60 years
    - U.K. Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
      - Hospital pharmacy
      - Retail pharmacy
      - Online pharmacy
  - Germany
  - France
  - Spain
  - Italy
  - Russia
  - Nordic
  - Benelux
  - Rest of Europe
- APAC
  - APAC Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
    - Pharmacological treatment
    - Surgical treatment
    - Minimally invasive procedures
    - Other treatments
  - APAC Benign Prostatic Hyperplasia Treatment Market, By End Use
    - Hospitals
    - Clinics
    - Ambulatory surgical centres
    - Specialty urology centers
  - APAC Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
    - Below 50 years
    - 50–60 years
    - Above 60 years
  - APAC Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
    - Hospital pharmacy
    - Retail pharmacy
    - Online pharmacy
  - China
    - China Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
      - Pharmacological treatment
      - Surgical treatment
      - Minimally invasive procedures
      - Other treatments
    - China Benign Prostatic Hyperplasia Treatment Market, By End Use
      - Hospitals
      - Clinics
      - Ambulatory surgical centres
      - Specialty urology centers
    - China Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
      - Below 50 years
      - 50–60 years
      - Above 60 years
    - China Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
      - Hospital pharmacy
      - Retail pharmacy
      - Online pharmacy
  - South Korea
  - Japan
  - India
  - Australia
  - Singapore
  - Taiwan
  - South East Asia
  - Rest of Asia-Pacific
- Middle East and Africa
  - Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
    - Pharmacological treatment
    - Surgical treatment
    - Minimally invasive procedures
    - Other treatments
  - Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, By End Use
    - Hospitals
    - Clinics
    - Ambulatory surgical centres
    - Specialty urology centers
  - Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
    - Below 50 years
    - 50–60 years
    - Above 60 years
  - Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
    - Hospital pharmacy
    - Retail pharmacy
    - Online pharmacy
  - UAE
    - UAE Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
      - Pharmacological treatment
      - Surgical treatment
      - Minimally invasive procedures
      - Other treatments
    - UAE Benign Prostatic Hyperplasia Treatment Market, By End Use
      - Hospitals
      - Clinics
      - Ambulatory surgical centres
      - Specialty urology centers
    - UAE Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
      - Below 50 years
      - 50–60 years
      - Above 60 years
    - UAE Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
      - Hospital pharmacy
      - Retail pharmacy
      - Online pharmacy
  - Turky
  - Saudi Arabia
  - South Africa
  - Egypt
  - Nigeria
  - Rest of MEA
- LATAM
  - LATAM Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
    - Pharmacological treatment
    - Surgical treatment
    - Minimally invasive procedures
    - Other treatments
  - LATAM Benign Prostatic Hyperplasia Treatment Market, By End Use
    - Hospitals
    - Clinics
    - Ambulatory surgical centres
    - Specialty urology centers
  - LATAM Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
    - Below 50 years
    - 50–60 years
    - Above 60 years
  - LATAM Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
    - Hospital pharmacy
    - Retail pharmacy
    - Online pharmacy
  - Brazil
    - Brazil Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
      - Pharmacological treatment
      - Surgical treatment
      - Minimally invasive procedures
      - Other treatments
    - Brazil Benign Prostatic Hyperplasia Treatment Market, By End Use
      - Hospitals
      - Clinics
      - Ambulatory surgical centres
      - Specialty urology centers
    - Brazil Benign Prostatic Hyperplasia Treatment Market, By Patient Age Group
      - Below 50 years
      - 50–60 years
      - Above 60 years
    - Brazil Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel
      - Hospital pharmacy
      - Retail pharmacy
      - Online pharmacy
  - Mexico
  - Argentina
  - Chile
  - Colombia
  - Rest of LATAM